NETHERLANDS DAYBOOK: Corio, ING Groep, Pharming, SBM Offshore

ING Groep NV (INGA), the biggest Dutch financial-services company, reported a 12 percent increase in first-quarter profit that beat analysts’ estimates as earnings at the insurance UNIT almost quadrupled.

Net income rose to 1.38 billion euros ($2.05 billion) from 1.23 billion euros in the first three months of 2010. Profit beat the 1.25 billion-euro average projection of eight analysts surveyed by Bloomberg. Year-earlier figures were restated because of a change in accounting policy related to the U.S. insurance operations.

WATCH TO WATCH: *Pharming (PHARM NA) is amending a late-stage clinical trial with its Rhucin drug. *SBM Offshore (SBMO NA) 1Q sales $683m.

EARNINGS: Preliminary ests, when available, all times CET *Corio (CORA) 5.40 p.m., 1Q net EU75.7m.


MARKETS: *The Amsterdam Exchanges Index (AEX) fell 1.3 percent to 355.91. *The Stoxx Europe 600 Index (SXXP) lost 1.4 percent to 278.52. *The Euro was at $1.4865 at 7:46 a.m.

To contact the reporter on this story: Maaike Noordhuis in Amsterdam

To contact the editor responsible for this story: Kenneth Wong at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.